The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
The safety of mRNA vaccines, hailed as a saviour in the covid-19 pandemic, has been called into question by the US ...
In recent years, messenger RNA (mRNA) vaccines have shown significant success in preventing viral and bacterial infections, ...
In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...
In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 in the US, EU, Canada, and Australia for adults aged 50 and older, ...
Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...
A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine—which designs nanotechnology-based ...
Every winter, Austin gets walloped by cedar fever: runny noses, scratchy throats, watering eyes, and canceled plans as ...
One of the new members is Adam Urato, a maternal-fetal medicine doctor based in Massachusetts who has long fought against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results